Castle Biosciences Inc (CSTL)
27.86
-0.14
(-0.50%)
USD |
NASDAQ |
Sep 27, 16:00
27.85
-0.01
(-0.04%)
After-Hours: 20:00
Castle Biosciences Research and Development Expense (Annual): 53.62M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 53.62M |
| December 31, 2022 | 44.90M |
| December 31, 2021 | 29.65M |
| December 31, 2020 | 13.26M |
| Date | Value |
|---|---|
| December 31, 2019 | 7.385M |
| December 31, 2018 | 4.854M |
| December 31, 2017 | 4.473M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
7.385M
Minimum
2019
53.62M
Maximum
2023
29.76M
Average
29.65M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Danaher Corp | 1.503B |
| Exact Sciences Corp | 425.88M |
| Illumina Inc | 1.354B |
| Mettler-Toledo International Inc | 185.28M |
| Natera Inc | 320.68M |